Intensive and/or dose dense induction chemotherapy, an autologous transplant strategy consisting of two semi-high-dose autologous transplants or equivalent in acute leukemia followed by an non-myeloablative reduced intensity conditioning allogeneic transplants in patients with donor compared to patients without donor (AML, ALL, CML, HD, NHL, neuroblastoma)